This view is reinforced by the presence of glucocorticoid (GRs) and cannabinoid receptors (CBR) across key brain areas implicated in depression, such as the hypothalamus, hippocampus, cortex, and amygdala [16, 17]. The gene discussed is CNR1; the disease is depressive symptom measurement.